MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Bio-Rad Laboratories Inc

Cerrado

SectorSalud

250.11 -0.02

Resumen

Variación precio

24h

Actual

Mínimo

248

Máximo

252.2

Métricas clave

By Trading Economics

Ingresos

780M

64M

Ventas

-82M

585M

BPA

2.54

Margen de beneficio

10.933

Empleados

7,700

EBITDA

75M

134M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+28.86% upside

Dividendos

By Dow Jones

Próximas Ganancias

31 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

64M

6.6B

Apertura anterior

250.13

Cierre anterior

250.11

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

157 / 375 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

3 jul 2025, 23:45 UTC

Adquisiciones, fusiones, absorciones

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

3 jul 2025, 23:42 UTC

Charlas de Mercado

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

3 jul 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

3 jul 2025, 23:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 jul 2025, 23:15 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

3 jul 2025, 22:59 UTC

Charlas de Mercado

Uranium Market About to Enter Lull -- Market Talk

3 jul 2025, 22:58 UTC

Charlas de Mercado

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

3 jul 2025, 22:47 UTC

Charlas de Mercado

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

3 jul 2025, 22:21 UTC

Ganancias

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

3 jul 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

3 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

3 jul 2025, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

3 jul 2025, 20:41 UTC

Charlas de Mercado

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

3 jul 2025, 20:41 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 jul 2025, 19:28 UTC

Charlas de Mercado

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

3 jul 2025, 19:03 UTC

Charlas de Mercado

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

3 jul 2025, 18:34 UTC

Charlas de Mercado

Gold Has Winning Week, But Down Day -- Market Talk

3 jul 2025, 18:18 UTC

Charlas de Mercado

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

3 jul 2025, 18:06 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 jul 2025, 18:06 UTC

Charlas de Mercado

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

3 jul 2025, 17:27 UTC

Charlas de Mercado

U.S. Oil Rig Count Continues to Slide -- Market Talk

3 jul 2025, 16:55 UTC

Ganancias

Travel Stocks Could Offer Investors a Glorious -2-

3 jul 2025, 16:55 UTC

Ganancias

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

3 jul 2025, 16:20 UTC

Charlas de Mercado

Correction to Health Care Roundup: Market Talk

3 jul 2025, 16:15 UTC

Charlas de Mercado

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

3 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

3 jul 2025, 16:05 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 jul 2025, 16:05 UTC

Charlas de Mercado

Gold Futures Fall Following Jobs Report -- Market Talk

3 jul 2025, 15:47 UTC

Ganancias

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

3 jul 2025, 15:36 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Comparación entre iguales

Cambio de precio

Bio-Rad Laboratories Inc Esperado

Precio Objetivo

By TipRanks

28.86% repunte

Estimación a 12 meses

Media 323 USD  28.86%

Máximo 387 USD

Mínimo 245 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Bio-Rad Laboratories Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

3

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

229.835 / 235.8095Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

157 / 375 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.